Literature DB >> 20705607

Turning the RING domain protein MdmX into an active ubiquitin-protein ligase.

Saravanakumar Iyappan1, Hans-Peter Wollscheid, Alejandro Rojas-Fernandez, Andreas Marquardt, Hao-Cheng Tang, Rajesh K Singh, Martin Scheffner.   

Abstract

The related RING domain proteins MdmX and Mdm2 are best known for their role as negative regulators of the tumor suppressor p53. However, although Mdm2 functions as a ubiquitin ligase for p53, MdmX does not have appreciable ubiquitin ligase activity. In this study, we performed a mutational analysis of the RING domain of MdmX, and we identified two distinct regions that, when replaced by the respective regions of Mdm2, turn MdmX into an active ubiquitin ligase for p53. Mdm2 and MdmX form homodimers as well as heterodimers with each other. One of the regions identified localizes to the dimer interface indicating that subtle conformational changes in this region either affect dimer stability and/or the interaction with the ubiquitin-conjugating enzyme UbcH5b. The second region contains the cryptic nucleolar localization signal of Mdm2 but is also assumed to be involved in the interaction with UbcH5b. Here, we show that this region has a significant impact on the ability of respective MdmX mutants to functionally interact with UbcH5b in vitro supporting the notion that this region serves two distinct functional purposes, nucleolar localization and ubiquitin ligase activity. Finally, evidence is provided to suggest that the RING domain of Mdm2 not only binds to UbcH5b but also acts as an allosteric activator of UbcH5b.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705607      PMCID: PMC2963378          DOI: 10.1074/jbc.M110.115113

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

2.  The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity.

Authors:  Masha V Poyurovsky; Christina Priest; Alex Kentsis; Katherine L B Borden; Zhen-Qiang Pan; Nikola Pavletich; Carol Prives
Journal:  EMBO J       Date:  2006-12-14       Impact factor: 11.598

Review 3.  Modification of proteins by ubiquitin and ubiquitin-like proteins.

Authors:  Oliver Kerscher; Rachael Felberbaum; Mark Hochstrasser
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

4.  Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of Mdm2.

Authors:  Rajesh K Singh; Saravanakumar Iyappan; Martin Scheffner
Journal:  J Biol Chem       Date:  2007-02-14       Impact factor: 5.157

Review 5.  Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.

Authors:  J-C Marine; S Francoz; M Maetens; G Wahl; F Toledo; G Lozano
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

6.  Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

Authors:  Shunbin Xiong; Carolyn S Van Pelt; Ana C Elizondo-Fraire; Geng Liu; Guillermina Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

7.  Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans.

Authors:  K Linke; P D Mace; C A Smith; D L Vaux; J Silke; C L Day
Journal:  Cell Death Differ       Date:  2008-01-25       Impact factor: 15.828

8.  Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53.

Authors:  Milka Kostic; Theresia Matt; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  J Mol Biol       Date:  2006-08-14       Impact factor: 5.469

9.  An essential function of the extreme C-terminus of MDM2 can be provided by MDMX.

Authors:  Stjepan Uldrijan; Willem-Jan Pannekoek; Karen H Vousden
Journal:  EMBO J       Date:  2006-12-14       Impact factor: 11.598

Review 10.  Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?

Authors:  Mark Wade; Geoffrey M Wahl
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

View more
  15 in total

1.  Mutational analysis of Mdm2 C-terminal tail suggests an evolutionarily conserved role of its length in Mdm2 activity toward p53 and indicates structural differences between Mdm2 homodimers and Mdm2/MdmX heterodimers.

Authors:  Pavlina Dolezelova; Katerina Cetkovska; Karen H Vousden; Stjepan Uldrijan
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

2.  Concepts in MDM2 Signaling: Allosteric Regulation and Feedback Loops.

Authors:  Anand Ponnuswamy; Ted Hupp; Robin Fåhraeus
Journal:  Genes Cancer       Date:  2012-03

3.  Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection.

Authors:  Heng Yang; Zhi Zheng; Lisa Y Zhao; Qiang Li; Daiqing Liao
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

Review 4.  RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination.

Authors:  Meredith B Metzger; Jonathan N Pruneda; Rachel E Klevit; Allan M Weissman
Journal:  Biochim Biophys Acta       Date:  2013-06-06

5.  Cryptic in vitro ubiquitin ligase activity of HDMX towards p53 is probably regulated by an induced fit mechanism.

Authors:  Karla Gisel Calderon-González; Ixaura Medina-Medina; Lucia Haronikova; Lenka Hernychova; Ondrej Bonczek; Lukas Uhrik; Vaclav Hrabal; Borivoj Vojtesek; Robin Fahraeus; Jesús Hernández-Monge; Vanesa Olivares-Illana
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

6.  MDM2 and MDMX: Alone and together in regulation of p53.

Authors:  Miriam Shadfan; Vanessa Lopez-Pajares; Zhi-Min Yuan
Journal:  Transl Cancer Res       Date:  2012-08       Impact factor: 1.241

7.  Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.

Authors:  Dipankar Ray; Paramita Ray; Daysha Ferrer-Torres; Zhuwen Wang; Derek Nancarrow; Hee-Won Yoon; May San Martinho; Tonaye Hinton; Scott Owens; Dafydd Thomas; Hui Jiang; Theodore S Lawrence; Jules Lin; Kiran Lagisetty; Andrew C Chang; David G Beer
Journal:  Gastroenterology       Date:  2019-11-09       Impact factor: 22.682

Review 8.  MDM2 oligomers: antagonizers of the guardian of the genome.

Authors:  P L Leslie; Y Zhang
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

9.  Structural analysis of MDM2 RING separates degradation from regulation of p53 transcription activity.

Authors:  Koji Nomura; Marta Klejnot; Dominika Kowalczyk; Andreas K Hock; Gary J Sibbet; Karen H Vousden; Danny T Huang
Journal:  Nat Struct Mol Biol       Date:  2017-05-29       Impact factor: 15.369

10.  Rearrangement of mitochondrial pyruvate dehydrogenase subunit dihydrolipoamide dehydrogenase protein-protein interactions by the MDM2 ligand nutlin-3.

Authors:  Luke Way; Jakub Faktor; Petra Dvorakova; Judith Nicholson; Borek Vojtesek; Duncan Graham; Kathryn L Ball; Ted Hupp
Journal:  Proteomics       Date:  2016-09       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.